TLDR Adobe CEO Shantanu Narayen is stepping down after 18 years, overshadowing a strong Q1 earnings beat. Q1 adjusted EPS came in at $6.06 on $6.4B revenue, toppingTLDR Adobe CEO Shantanu Narayen is stepping down after 18 years, overshadowing a strong Q1 earnings beat. Q1 adjusted EPS came in at $6.06 on $6.4B revenue, topping

Adobe (ADBE) Stock Slides 7% Despite Earnings Beat – CEO Steps Down

2026/03/13 16:37
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Adobe CEO Shantanu Narayen is stepping down after 18 years, overshadowing a strong Q1 earnings beat.
  • Q1 adjusted EPS came in at $6.06 on $6.4B revenue, topping estimates of $5.87 EPS and $6.28B revenue.
  • Stock fell 6.7% in after-hours trading; it’s now down 23% year-to-date and 60% from its all-time high.
  • Barclays downgraded ADBE to Equalweight, cutting its price target from $335 to $275, citing AI headwinds and leadership uncertainty.
  • AI ARR tripled year-over-year, but generative AI tools like Firefly are cannibalizing Adobe Stock revenue.

Adobe beat its Q1 numbers, but investors didn’t care. A CEO exit and growing AI concerns sent the stock sliding after hours.

Shantanu Narayen, who has led Adobe for 18 years, announced he is stepping down. He will stay in the role until a replacement is found and will remain as board chair to help with the transition.


ADBE Stock Card
Adobe Inc., ADBE

The announcement came the same evening Adobe reported fiscal first-quarter results that topped Wall Street expectations. Adjusted earnings came in at $6.06 per share on revenue of $6.4 billion, ahead of analyst estimates of $5.87 per share and $6.28 billion in revenue.

Despite the beat, the stock dropped 6.7% in after-hours trading. ADBE is now down 23% year-to-date and sits roughly 60% below its all-time closing high of $688.37, set in November 2021.

AI: Double-Edged Sword

Adobe has been caught in a difficult spot with artificial intelligence. The worry among investors is that AI tools can replace what creative software does — and that Adobe is more exposed to this than most.

The numbers offer a mixed read. On one hand, Adobe’s AI-first annual recurring revenue more than tripled year-over-year. On the other, Barclays analyst Saket Kalia pointed out that generative AI tools like Adobe Firefly are eating into Adobe Stock sales. Users are generating images with text prompts instead of buying stock photos.

Kalia also flagged that faster growth in freemium users for Firefly and Express is pulling down average revenue per user. Barclays downgraded the stock to Equalweight from Overweight and cut its price target to $275 from $335.

Adobe had 80 million monthly active users for its freemium products at the end of Q1, with generative credit usage up 45% quarter-over-quarter.

What Comes Next

For Q2, Adobe guided for earnings of $5.80 to $5.85 per share on revenue of $6.43 to $6.48 billion. The earnings midpoint is ahead of Wall Street’s $5.68 estimate.

The company left its fiscal 2026 ARR guidance unchanged, with the second half expected to benefit from enterprise tools and freemium monetization.

Barclays noted the CEO transition adds another layer of uncertainty. With an ARR base above $25 billion, any meaningful change in direction will take time.

As of March 13, ADBE was trading at $269.78, down 28.6% over the past year.

The post Adobe (ADBE) Stock Slides 7% Despite Earnings Beat – CEO Steps Down appeared first on CoinCentral.

Market Opportunity
Audiera Logo
Audiera Price(BEAT)
$0.41736
$0.41736$0.41736
+1.45%
USD
Audiera (BEAT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.